Ranitidine, known and marketed under the trade name Zantac, belongs to the histamine H2 receptor blockers, which decrease gastric acidity. It has been largely used for treating peptic ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. Ranitidine is also available Over-the-counter to prevent and treat heartburn. Since 2020 regulatory agencies requested pharmaceutical companies to withdraw it from the market due to contamination of N-Nitrosodimethylamine NDMA.
Ranitidine is available as an Injection solution with a
strength of 25 mg/mL, syrup with a
strength of 15 mg/mL, and tablets with a strength of 75 mg, 150 mg, and 300 mg.
The correct answer is D.
References:
https://www.rxlist.com/consumer_ranitidine_zantac/drugs-condition.htm
Comments
Post a Comment